Literature DB >> 11070405

Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia?

M Vieth1, B Masoud, A Meining, M Stolte.   

Abstract

BACKGROUND: Since Helicobacter pylori (Hp) infection provokes intestinal and gastric metaplasia, the question arises whether the specialized metaplasia (Barrett's mucosa (BM)) and dysplasia or carcinoma in Barrett's epithelium seen in gastro-oesophageal reflux disease (GORD) might not also be correlated with Hp infection, or whether the latter offers protection against Barrett's oesophagus and Barrett's adenocarcinoma. PATIENTS: Gastric and oesophageal biopsies obtained from a total of 2,201 patients were analysed retrospectively. 297 of these patients had GORD (age 53.5 +/- 13.4 years; m:f ratio 2.1:1), 1,192 patients had BM (age 62.8 +/- 14.6 years; m:f 2.3:1) with or without neoplasia. 1,054 of these patients were diagnosed as having BM alone, 138 patients having BM neoplasia (high-grade dysplasia or adenocarcinoma). Patients with BM and low-grade dysplasia were excluded from this study because of the uncertainty in differentiating low-grade dysplasia from regenerative epithelium. A total of 712 patients with non-ulcer dyspepsia (NUD; average age 40.0 +/- 16.1 years; m:f 0.3:1) served as a control group.
RESULTS: The percentage of Hp infection did not differ between patients with GORD with (53.3%)/without BM (51.4%) and neoplasia (47.8%), but is statistically significantly lower than in patients with NUD (65.7%).
CONCLUSION: Our analysis shows that patients with GORD and Hp infection have no increased risk for the development of BM or neoplasia in BM. Since Hp infection is significantly less frequent in GORD than in NUD patients, a protective effect of the Hp infection is a possibility worth discussing. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 11070405     DOI: 10.1159/000007820

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  23 in total

Review 1.  Adenocarcinoma of oesophagus: what exactly is the size of the problem and who is at risk?

Authors:  J Lagergren
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  Helicobacter pylori and esophageal cancer risk: a meta-analysis.

Authors:  Farhad Islami; Farin Kamangar
Journal:  Cancer Prev Res (Phila)       Date:  2008-10

Review 3.  Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm.

Authors:  Beverly R E A Dixon; Rafat Hossain; Rachna V Patel; Holly M Scott Algood
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

4.  Oesophageal and proximal gastric adenocarcinomas are rare after detection of Helicobacter pylori infection.

Authors:  Shria Kumar; David C Metz; Gregory G Ginsberg; David E Kaplan; David S Goldberg
Journal:  Aliment Pharmacol Ther       Date:  2020-03-04       Impact factor: 8.171

5.  Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus.

Authors:  Stuart J Thomas; Lucy Almers; Jennifer Schneider; James E Graham; Peter J Havel; Douglas A Corley
Journal:  Dig Dis Sci       Date:  2015-09-22       Impact factor: 3.199

6.  Helicobacter pylori induces apoptosis in Barrett's-derived esophageal adenocarcinoma cells.

Authors:  Andrew D Jones; Kathy D Bacon; Blair A Jobe; Brett C Sheppard; Clifford W Deveney; Michael J Rutten
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

Review 7.  Systems-wide analyses of mucosal immune responses to Helicobacter pylori at the interface between pathogenicity and symbiosis.

Authors:  Barbara Kronsteiner; Josep Bassaganya-Riera; Casandra Philipson; Monica Viladomiu; Adria Carbo; Vida Abedi; Raquel Hontecillas
Journal:  Gut Microbes       Date:  2016

8.  Helicobacter pylori infection in a pig model is dominated by Th1 and cytotoxic CD8+ T cell responses.

Authors:  Barbara Kronsteiner; Josep Bassaganya-Riera; Casandra Philipson; Monica Viladomiu; Adria Carbo; Mireia Pedragosa; Salvador Vento; Raquel Hontecillas
Journal:  Infect Immun       Date:  2013-07-29       Impact factor: 3.441

Review 9.  Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis.

Authors:  Fa-Jun Xie; Yi-Ping Zhang; Qiu-Qing Zheng; Hong-Chuan Jin; Fa-Liang Wang; Ming Chen; Lan Shao; De-Hong Zou; Xin-Min Yu; Wei-Min Mao
Journal:  World J Gastroenterol       Date:  2013-09-28       Impact factor: 5.742

10.  Interleukin-21 (IL-21) Downregulates Dendritic Cell Cytokine Responses to Helicobacter pylori and Modulates T Lymphocyte IL-17A Expression in Peyer's Patches during Infection.

Authors:  Sharia Yasmin; Beverly R E A Dixon; Danyvid Olivares-Villagómez; Holly M Scott Algood
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.